Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 20 of 30)As of 22-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
10-Nov-09Brean Murray & Co., Inc.Jose HarescoHOLX: Beats F4Q Estimates, but Guidance Disappoints for FY10 as Slow Growth Turns into No Growth5$10  View Abstract
10-Nov-09Brean Murray & Co., Inc.Jonathan M. Aschoff PhD, Andrey Glukhov CFA, Michael Gaugler, Daniel Fidell, Jose Haresco, Bret JonesMorning Insight (ERTS, GAME, NTES, PWRD, SNDA, MIPI, HYTM, HOLX, QSII, COMV, SWWC)10$254 Stars 4 Stars View Abstract
9-Nov-09Brean Murray & Co., Inc.Jose HarescoBEAT: MCOT Case Volume Grows 46% YoY Despite Revenue Impact of Lower Reimbursement; Lowering Estimates and Downgrading to Hold5$10  View Abstract
9-Nov-09Brean Murray & Co., Inc.Eric M. Beder, Michael Gaugler, Daniel Fidell, Jose HarescoMorning Insight (BEAT, ANF, MFB, URBN, AEO, ANF, ARO, BEBE, CACH, GES, JCG, NWY, TRLG, URBN, WTSLA, YORW, NCOC, Water Works Weekly, Clean Energy Weekly Review, Utility Weekly Review)15$504 Stars  View Abstract
6-Nov-09Brean Murray & Co., Inc.Jose HarescoVOLC: An Uneventful Quarter Has Us Looking Ahead to Sustained Profitability in 20105$10  View Abstract
6-Nov-09Brean Murray & Co., Inc.Jose HarescoOMPI: Seasonality Is a Double-Edged Sword; 3Q Miss Made Up For By Encouraging 4Q Guidance4$10  View Abstract
6-Nov-09Brean Murray & Co., Inc.Eric M. Beder, Ryan Worst CFA, Andrey Glukhov CFA, Michael Gaugler, Daniel Fidell, Jose Haresco, Ling Wang CFA, Bret Jones, Jeremy SussmanMorning Insight (BEBE, AEO, ANF, ARO, URBN, WTSLA, CCC, FTEK, ECLP, VOLC, OMPI, ARIA, ATVI, SJI, IGT)14$504 Stars 4 Stars View Abstract
5-Nov-09Brean Murray & Co., Inc.Jose HarescoAMMD: 3Q Results Beat our Street-High Estimates; Management Guides Above Street as Upbeat Commentary on Growth Opportunities Dominates the Discussion5$10  View Abstract
5-Nov-09Brean Murray & Co., Inc.Eric M. Beder, Jonathan M. Aschoff PhD, Andrey Glukhov CFA, Michael Gaugler, Daniel Fidell, Jose Haresco, Bret JonesMorning Insight (AWR, WRC, AMMD, PFWD, NKTR, CNSO, MDVN, SGMO, ELON, CHG, CNP, NST, NU, UIL, UTL, VVC, THQI)16$504 Stars 4 Stars View Abstract
4-Nov-09Brean Murray & Co., Inc.Jose HarescoVOLC: 3Q Earnings Preview: Expecting No Surprises4$10  View Abstract
4-Nov-09Brean Murray & Co., Inc.Eric M. Beder, Jonathan M. Aschoff PhD, Michael Gaugler, Jose Haresco, Ling Wang CFA, Ananda Baruah, Jeremy SussmanMorning Insight (ANR, JRCC, PBI, MWA, TRLG, AEO, ANF, ARO, URBN, VOLC, ARIA, PARD)11$254 Stars  View Abstract
2-Nov-09Brean Murray & Co., Inc.Jose HarescoALGN: Management Meetings Focus on Growth Opportunities5$10  View Abstract
2-Nov-09Brean Murray & Co., Inc.Jonathan M. Aschoff PhD, Michael Gaugler, Daniel Fidell, Jose Haresco, Jeremy SussmanMorning Insight (CCC, Water Works Weekly, ALGN, ACI, UIL, Utility Weekly Review, Clean Energy Weekly Review)13$504 Stars  View Abstract
30-Oct-09Brean Murray & Co., Inc.Jose HarescoCRDC: Dropping Coverage4$10  View Abstract
30-Oct-09Brean Murray & Co., Inc.Jose HarescoPMTI: Third Quarter in Line with Estimates; Management Tone Improves4$10  View Abstract
30-Oct-09Brean Murray & Co., Inc.Ryan Worst CFA, Andrey Glukhov CFA, Daniel Fidell, Jose Haresco, Ling Wang CFA, Bret Jones, Ananda BaruahMorning Insight (AMSC, BYI, PFWD, ATHN, PMTI, IMGN, EK, IM, AVT, MCRS)13$504 Stars 4 Stars View Abstract
23-Oct-09Brean Murray & Co., Inc.Jose HarescoALGN: Align Beats as Invisalign Teen Successfully Begins to Mitigate Seasonality; Raising Estimates and Target Price5$10  View Abstract
23-Oct-09Brean Murray & Co., Inc.Jose Haresco, Bret Jones, Ananda Baruah, Jeremy SussmanMorning Insight (CNX, ALGN, CPSI, WDC, XRX)8$254 Stars  View Abstract
22-Oct-09Brean Murray & Co., Inc.Jose HarescoOMPI: Pullback Offers Entry Ahead of the Quarter; Raising Target Price to $154$10  View Abstract
22-Oct-09Brean Murray & Co., Inc.Jose HarescoSTJ: St. Jude Offers an Upbeat Long-term View; Near-term Risks Remain, However4$10  View Abstract
Next 10

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.